Morton Brown Family Wealth’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19K Buy
148
+29
+24% +$3.39K ﹤0.01% 163
2026
Q1
$14.3K Hold
119
﹤0.01% 173
2025
Q4
$12.5K Buy
119
+19
+19% +$1.78K ﹤0.01% 182
2025
Q3
$8.39K Sell
100
-82
-45% -$6.75K ﹤0.01% 196
2025
Q2
$14.4K Hold
182
﹤0.01% 168
2025
Q1
$16.3K Buy
182
+166
+1,038% +$15.5K 0.01% 159
2024
Q4
$1.59K Hold
16
﹤0.01% 240
2024
Q3
$1.82K Hold
16
﹤0.01% 227
2024
Q2
$1.99K Hold
16
﹤0.01% 193
2024
Q1
$2.11K Sell
16
-400
-96% -$49.3K ﹤0.01% 191
2023
Q4
$45.4K Buy
416
+400
+2,500% +$41.5K 0.02% 106
2023
Q3
$1.65K Hold
16
﹤0.01% 165
2023
Q2
$1.85K Buy
+16
New +$1.82K ﹤0.01% 156
2022
Q4
Sell
-377
Closed -$38.5K 202
2022
Q3
$32K Sell
377
-99
-21% -$8.84K 0.03% 78
2022
Q2
$43K Buy
476
+101
+27% +$8.95K 0.03% 70
2022
Q1
$31K Hold
375
0.02% 84
2021
Q4
$29K Buy
+375
New +$29.9K 0.02% 90

Other funds holding MRK

Morton Brown Family Wealth's MRK Position: Q2 2026 in Review

Morton Brown Family Wealth increased its Merck (MRK) stake by 24% in Q2 2026, buying an estimated $3.39K and bringing the position to 148 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #163.

Morton Brown Family Wealth first reported a position in MRK in Q4 2021 and has held it in 17 quarters since. The position peaked at $45.4K in Q4 2023. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Morton Brown Family Wealth held 148 shares of Merck worth $19K as of Q2 2026.
  • Morton Brown Family Wealth bought 29 Merck shares in Q2 2026, an estimated $3.39K.
  • Merck made up ﹤0.01% of Morton Brown Family Wealth's portfolio in Q2 2026, its #163 holding.
  • Morton Brown Family Wealth first reported a position in Merck in Q4 2021 and has held it in 17 quarters since.
  • Morton Brown Family Wealth's Merck position peaked at $45.4K in Q4 2023.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Morton Brown Family Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.